Colgate-Palmolive Company $CL Shares Sold by Pictet Asset Management Holding SA

Pictet Asset Management Holding SA decreased its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 1.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 459,446 shares of the company’s stock after selling 9,060 shares during the period. Pictet Asset Management Holding SA’s holdings in Colgate-Palmolive were worth $36,305,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Maseco LLP acquired a new stake in Colgate-Palmolive in the 4th quarter worth about $27,000. Copia Wealth Management acquired a new position in shares of Colgate-Palmolive during the 3rd quarter valued at about $29,000. Cloud Capital Management LLC purchased a new position in shares of Colgate-Palmolive during the 3rd quarter worth about $30,000. Global Wealth Strategies & Associates lifted its holdings in shares of Colgate-Palmolive by 300.0% during the 4th quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock worth $32,000 after acquiring an additional 300 shares during the period. Finally, Grove Bank & Trust boosted its position in shares of Colgate-Palmolive by 182.6% in the fourth quarter. Grove Bank & Trust now owns 407 shares of the company’s stock worth $32,000 after acquiring an additional 263 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Insider Buying and Selling

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 97,843 shares of the company’s stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total value of $9,223,659.61. Following the completion of the transaction, the chief financial officer owned 55,310 shares in the company, valued at $5,214,073.70. This represents a 63.89% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Panagiotis Tsourapas sold 15,000 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the sale, the chief operating officer owned 10,415 shares in the company, valued at $1,018,691.15. This represents a 59.02% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 184,683 shares of company stock worth $17,486,693 over the last three months. 0.43% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. Royal Bank Of Canada set a $102.00 price target on shares of Colgate-Palmolive in a research report on Thursday, April 9th. Morgan Stanley lowered their price objective on shares of Colgate-Palmolive from $100.00 to $95.00 and set an “overweight” rating for the company in a research note on Thursday, April 23rd. Wall Street Zen downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Sunday, March 29th. TD Cowen reaffirmed a “hold” rating and issued a $85.00 target price on shares of Colgate-Palmolive in a research report on Tuesday, March 31st. Finally, JPMorgan Chase & Co. lowered their price target on Colgate-Palmolive from $97.00 to $95.00 and set an “overweight” rating for the company in a research report on Friday, April 17th. Twelve research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $95.56.

Colgate-Palmolive Price Performance

CL opened at $84.50 on Thursday. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33. The company has a 50 day moving average of $88.12 and a two-hundred day moving average of $84.05. The company has a market cap of $67.80 billion, a P/E ratio of 32.25, a P/E/G ratio of 4.31 and a beta of 0.34. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The business had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.91 EPS. On average, analysts expect that Colgate-Palmolive Company will post 3.85 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be paid a dividend of $0.53 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date is Monday, April 20th. Colgate-Palmolive’s payout ratio is presently 80.92%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.